Pharmacokinetics of inhaled drugs

British Journal of Clinical Pharmacology
B J Lipworth

Abstract

1. A high therapeutic ratio for the inhaled route of administration is achieved by delivering doses which achieve a high local concentration in the lung and relatively low levels of systemic absorption. 2. Pharmacokinetic evaluation of drug absorption from the lungs provides an accurate and reproducible method for comparing different inhaler delivery systems, as well as for evaluating bioequivalence of generic drug formulations. 3. The measurement of drug absorption from the lungs may also be applied to assess the effects of inhalation technique on drug delivery in vivo. For example with salbutamol delivered via a large volume spacer, lung bioavailability has been shown to be altered by factors such as the number of actuated puffs, inhalation-actuation delay and washing procedure. 4. Differences in drug delivery to the lungs between dry powder reservoir and pressurised metered-dose aerosol devices translate directly into commensurate differences in clinical efficacy for delivery of both inhaled beta 2-adrenoceptor agonists and corticosteroids. 5. For inhaled corticosteroids, pharmacokinetic evaluation using oral charcoal to obviate alimentary absorption may be applied to quantify the relative gut and lung components of systemic...Continue Reading

Citations

Aug 5, 1998·British Journal of Clinical Pharmacology·B J Lipworth, D J Clark
Apr 25, 2001·British Journal of Clinical Pharmacology·S J Fowler, B J Lipworth
Mar 1, 2002·Biopharmaceutics & Drug Disposition·A NoltingW Abramowitz
Oct 31, 2002·American Journal of Respiratory and Critical Care Medicine·Ivan GoldsteinJean-Jacques Rouby
Dec 19, 2003·Journal of Clinical Pharmacology·Walter K KraftScott A Waldman
Oct 8, 2005·Respiration; International Review of Thoracic Diseases·Peter von Wichert, Carola Seifart
Sep 2, 2008·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Kim SeltingRajiv Dhand
Jul 22, 2008·British Journal of Clinical Pharmacology·Klaus BønnelykkeHans Bisgaard
Feb 7, 2015·Expert Review of Clinical Immunology·Stefan ZielenRalf Schubert
Jul 17, 2018·Expert Review of Respiratory Medicine·Rosanel AmaroAntoni Torres
Apr 24, 1999·British Journal of Clinical Pharmacology·J AnhøjB J Lipworth
Dec 6, 2005·Cancer Chemotherapy and Pharmacology·Frédéric GagnadouxEtienne Lemarié
Sep 1, 2007·American Journal of Respiratory and Critical Care Medicine·Patrick A FlumeUNKNOWN Cystic Fibrosis Foundation, Pulmonary Therapies Committee
May 25, 2011·Biomedical Microdevices·Cinzia Anna VenturaSilvana Tommasini
Jul 30, 2009·Expert Opinion on Drug Delivery·Chiraz Jaafar-MaalejHatem Fessi
Jan 1, 2010·Expert Review of Clinical Pharmacology·Simon MantellMike Trevethick
Mar 20, 2013·British Journal of Clinical Pharmacology·Christian BartelsGuenther Kaiser
Apr 5, 2017·Biopharmaceutics & Drug Disposition·Konstantina SouleleVangelis Karalis
Aug 11, 2017·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Hirokazu Okamoto
Sep 29, 2018·Expert Opinion on Drug Metabolism & Toxicology·Maria Gabriella MateraMario Cazzola
Jul 29, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·B J Lipworth, C M Jackson
Jun 10, 2003·Clinical Pharmacokinetics·Stephen P Newman
Sep 11, 2001·American Journal of Therapeutics·V V Ranade
Jun 22, 2005·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·Frédéric GagnadouxEtienne Lemarié
Apr 6, 2007·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Hirokazu Okamoto, Kazumi Danjo
Nov 4, 2005·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Marjolein P de VriesC P van Schayck
Mar 6, 2007·British Journal of Clinical Pharmacology·Klaus BønnelykkeHans Bisgaard
Jul 9, 2011·Investigational New Drugs·Paul ZarogoulidisKostantinos Zarogoulidis
Dec 23, 2010·Expert Opinion on Drug Delivery·Remigius U Agu, Michael I Ugwoke
Aug 8, 2013·Therapeutic Delivery·Mariam Ibrahim, Lucila Garcia-Contreras
Jul 29, 2017·Advanced Healthcare Materials·Ranjith Kumar KankalaAi-Zheng Chen
Oct 8, 2016·Critical Care : the Official Journal of the Critical Care Forum·Jayesh DhananiJason A Roberts
Mar 28, 2018·Clinical Drug Investigation·Julia PaikRoy A Pleasants

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Related Papers

The British Journal of General Practice : the Journal of the Royal College of General Practitioners
C Jackson, B J Lipworth
Schweizerische medizinische Wochenschrift
J H Wildhaber
Clinical Pharmacokinetics
D J Clark, B J Lipworth
Clinical Pharmacokinetics
R Donnelly, J P Seale
© 2021 Meta ULC. All rights reserved